Elisa De Carlo

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

BRAF class II-III mutations in NSCLC: a single center experience.

BRAF class II-III mutations in NSCLC: a single center experience.

Journal: Frontiers in oncology

Published: October 02, 2025

A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020).

A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 14, 2025

Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Journal: Cancers

Published: February 11, 2025

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Journal: International journal of molecular sciences

Published: December 20, 2024

EML4-ALK: Update on ALK Inhibitors.

EML4-ALK: Update on ALK Inhibitors.

Journal: International journal of molecular sciences

Published: December 04, 2024

Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: November 22, 2024

Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance.

Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance.

Journal: International journal of molecular sciences

Published: October 31, 2024

Targeted Therapy in Mesotheliomas: Uphill All the Way.

Targeted Therapy in Mesotheliomas: Uphill All the Way.

Journal: Cancers

Published: April 06, 2024

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Journal: Frontiers in oncology

Published: October 04, 2023

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer.

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: June 10, 2023

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.

Journal: International journal of molecular sciences

Published: May 21, 2023

Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC.

Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 03, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026